0

Rheumatoid Arthritis Collection
 1-20 of 214 Articles
Original Research |  20 August 2013
Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: A Randomized Trial
Joel Kremer, MD; Zhan-Guo Li, MD, PhD; Stephen Hall, MD; et al.
Ann Intern Med. 2013;159(4):253-261. doi:10.7326/0003-4819-159-4-201308200-00006
Updates |  18 June 2013
Update in Rheumatology: Evidence Published in 2012
Atul Deodhar, MD
Ann Intern Med. 2013;158(12):903-906. doi:10.7326/0003-4819-158-12-201306180-00107
Original Research |  6 March 2012 FREE
Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis: A Randomized Trial
Marije F. Bakker, PhD; Johannes W.G. Jacobs, PhD, MD; Paco M.J. Welsing, PhD; et al.
Ann Intern Med. 2012;156(5):329-339. doi:10.7326/0003-4819-156-5-201203060-00004
Editorials |  6 March 2012
Combination Therapy Including Glucocorticoids: The New Gold Standard for Early Treatment in Rheumatoid Arthritis?
John Richard Kirwan, MD
Ann Intern Med. 2012;156(5):390-391. doi:10.7326/0003-4819-156-5-201203060-00014
Reviews |  6 April 2010
Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis
Penny F. Whiting, PhD; Nynke Smidt, PhD; Jonathan A.C. Sterne, PhD; et al.
Ann Intern Med. 2010;152(7):456-464. doi:10.7326/0003-4819-152-7-201004060-00010
Editorials |  3 November 2009
Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed?
Maarten Boers, MSc, MD, PhD
Ann Intern Med. 2009;151(9):668-669. doi:10.7326/0003-4819-151-9-200911030-00013
Articles |  18 August 2009 FREE
Comparison of Tripterygium wilfordii Hook F Versus Sulfasalazine in the Treatment of Rheumatoid Arthritis: A Randomized Trial
Raphaela Goldbach-Mansky, MD, MHS; Mildred Wilson, RN; Roy Fleischmann, MD; et al.
Ann Intern Med. 2009;151(4):229-240. doi:10.7326/0003-4819-151-4-200908180-00005
Reviews |  15 January 2008 FREE
Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis
Katrina E. Donahue, MD, MPH; Gerald Gartlehner, MD, MPH; Daniel E. Jonas, MD, MPH; et al.
Ann Intern Med. 2008;148(2):124-134. doi:10.7326/0003-4819-148-2-200801150-00192
Editorials |  15 January 2008 FREE
Comparative Effectiveness of Treatments for Rheumatoid Arthritis
Jeffrey Siegel, MD
Ann Intern Med. 2008;148(2):162-163. doi:10.7326/0003-4819-148-2-200801150-00012
Reviews |  5 June 2007
Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis
Kunihiro Nishimura, MD, MPH, MS; Daisuke Sugiyama, MD, MPH; Yoshinori Kogata, MD; et al.
Ann Intern Med. 2007;146(11):797-808. doi:10.7326/0003-4819-146-11-200706050-00008
Editorials |  5 June 2007
Anti–Cyclic Citrullinated Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis: Bayes Clears the Haze
Axel Finckh, MD, MS; Matthew H. Liang, MD, MPH
Ann Intern Med. 2007;146(11):816-817. doi:10.7326/0003-4819-146-11-200706050-00011
Articles |  20 March 2007
Comparison of Treatment Strategies in Early Rheumatoid Arthritis: A Randomized Trial
Yvonne P.M. Goekoop-Ruiterman, MD; Jeska K. de Vries-Bouwstra, MD; Cornelia F. Allaart, MD; et al.
Ann Intern Med. 2007;146(6):406-415. doi:10.7326/0003-4819-146-6-200703200-00005
Editorials |  20 March 2007
The BeSt Way to Treat Early Rheumatoid Arthritis?
James R. O'Dell, MD
Ann Intern Med. 2007;146(6):459-460. doi:10.7326/0003-4819-146-6-200703200-00014
Articles |  20 June 2006
Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis: A Randomized Trial
Joel M. Kremer, MD; Harry K. Genant, MD; Larry W. Moreland, MD; et al.
Ann Intern Med. 2006;144(12):865-876. doi:10.7326/0003-4819-144-12-200606200-00003
Editorials |  20 June 2006
Abatacept in Rheumatoid Arthritis: A New Branch on the “Biologics” Tree
Maarten Boers, MSc, MD, PhD
Ann Intern Med. 2006;144(12):933-935. doi:10.7326/0003-4819-144-12-200606200-00012
Articles |  21 February 2006
Preclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis
Mary J. Roman, MD; Elfi Moeller, AB; Adrienne Davis, AB; et al.
Ann Intern Med. 2006;144(4):249-256. doi:10.7326/0003-4819-144-4-200602210-00006
Articles |  5 November 2002
Concomitant Leflunomide Therapy in Patients with Active Rheumatoid Arthritis despite Stable Doses of Methotrexate: A Randomized, Double-Blind, Placebo-Controlled Trial
Joel M. Kremer, MD; Mark C. Genovese, MD; Grant W. Cannon, MD; et al.
Ann Intern Med. 2002;137(9):726-733. doi:10.7326/0003-4819-137-9-200211050-00007
Reviews |  18 June 2002
Rheumatoid Arthritis—A Molecular Understanding
J. Bruce Smith, MD; Mark K. Haynes, PhD
Ann Intern Med. 2002;136(12):908-922. doi:10.7326/0003-4819-136-12-200206180-00012
Therapeutics |  May/Jun 2002
Review: Adding newer disease-modifying drugs or biological agents to methotrexate improved rheumatoid arthritis symptoms
Deborah P.M. Symmons, MD
Ann Intern Med. 2002;136(3):97. doi:10.7326/ACPJC-2002-136-3-097
Articles |  1 January 2002
Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Amalia A. van Everdingen, MD; Johannes W.G. Jacobs, MD, PhD; Dirk R. Siewertsz van Reesema, MD; et al.
Ann Intern Med. 2002;136(1):1-12. doi:10.7326/0003-4819-136-1-200201010-00006
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)